Systemic Lupus Erythematosus Clinical Trials in Aurora, Colorado

4 studies are recruiting for systemic lupus erythematosus in Aurora, Colorado right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

    The purpose of this study is to evaluate the ability of dapirolizumab pegol (DZP) as an add-on treatment to standard of care (SOC) medication to achieve clinically relevant long term improvement of moderate to severe disease activity.

    Stage
    Phase 3
    Ages
    16 and older
    Site
    Sl0044 50719, Aurora, Colorado
    Locations
    242 in total
    Run by
    UCB Biopharma SRL

    See if you can join NCT06617325 on ClinicalTrials.gov

  2. A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

    The main objective is to assess the safety and tolerability of inebilizumab in adult participants with active and refractory systemic lupus erythematosus (SLE) with nephritis (Subprotocol A) and to assess the safety and tolerability of subcutaneous (SC) blinatumomab in adult participants with activ…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    University of Colorado, Aurora, Colorado
    Locations
    58 in total
    Run by
    Amgen

    See if you can join NCT06570798 on ClinicalTrials.gov

  3. Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

    The purpose of this study is to evaluate long-term safety and tolerability of ianalumab in participants with systemic lupus erythematosus who have previously completed the treatment period in one of the two SIRIUS-SLE core studies (CVAY736F12301 or CVAY736F12302).

    Stage
    Phase 3
    Ages
    12 to 100
    Site
    University of Colorado Denver, Aurora, Colorado
    Locations
    143 in total
    Run by
    Novartis Pharmaceuticals

    See if you can join NCT06133972 on ClinicalTrials.gov

  4. A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants

    This study will assess the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of GSK4527363 in healthy participants (Part A), participants with active SLE (Part B), healthy participants of Chinese and Japanese descent (Part C), and participants with interstitial lung diseas…

    Stage
    Phase 1
    Ages
    18 to 65
    Site
    GSK Investigational Site, Aurora, Colorado
    Locations
    28 in total
    Run by
    GlaxoSmithKline

    See if you can join NCT06576271 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.